y theoretically prove useful (e.g., inhibition of IL-6 by tocilizumab).[24]

Other Therapies
Other treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc.